Caribou Biosciences Inc (CRBU) Stock: A Year of Declines and Increases

DOYU

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Caribou Biosciences Inc’s current trading price is -71.15% away from its 52-week high, while its distance from the 52-week low is 59.09%. The stock’s price range for this time frame has been between $0.66 and $3.64. The trading volume of the company’s shares in the Healthcare reached around 1.09 million for the day, which was evidently higher than the average daily volume of 1.05 million over the last three months.

The stock market performance of Caribou Biosciences Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $3.64 on 05/20/24, while the lowest price during the same time frame was $0.66, recorded on 04/07/25.

How Financial Performance Impacts Market Capitalization

Caribou Biosciences Inc (CRBU) has experienced a quarterly decline of -26.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 97.66M and boasts a workforce of 147 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.1596, with a change in price of -0.7500. Similarly, Caribou Biosciences Inc recorded 1,190,212 in trading volume during the last 100 days, posting a change of -41.67%.

How CRBU’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CRBU stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.11.

CRBU Stock Stochastic Average

The raw stochastic average for Caribou Biosciences Inc over the last 50 days is presently at 78.00%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 100.00%. Further, the company’s Stochastic %K and %D values for the last 20 days were 87.39% and 70.03%, respectively.

CRBU Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Year to date metric has recorded a loss of -33.96%.However, over the last six months, we can see a stronger performance of -52.27%. Over the last 30 days, the price of CRBU has fallen by 42.86%. And in the last five days, it has surged by 28.35%.

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.